Sanofi
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Sanofi generated cash of $10,258,000,000, which is less than the previous year. Cash used in financing activities reached the amount of -$8,052,000,000 last year. Net change in cash is therefore -$4,026,000,000.
Cash Flow
| 2014 | 7.69B | -3.46B | -5.18B |
|---|---|---|---|
| 2015 | 8.92B | -3.25B | -3.60B |
| 2016 | 8.18B | -2.63B | -3.99B |
| 2017 | 7.37B | 639M | -7.90B |
| 2018 | 5.54B | -12.87B | 3.93B |
| 2019 | 7.74B | -1.05B | -4.19B |
| 2020 | 7.41B | 3.61B | -6.48B |
| 2021 | 10.52B | -7.29B | -7.05B |
| 2022 | 10.52B | -2.07B | -5.82B |
| 2023 | 10.25B | -6.2B | -8.05B |
SNY Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 12.73B | 10.09B | 13.91B | 9.42B | 6.92B | 10.31B | 10.27B | 9.14B | 7.34B | 8.25B |
Operating activities | ||||||||||
Net income | 5.4B | 8.37B | 6.22B | 12.29B | 2.80B | 4.30B | 8.43B | 4.70B | 4.28B | 4.39B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 3.77B | 3.42B | 3.35B | 3.67B | 7.45B | 4.27B | 3.68B | 3.30B | 4.27B | 3.28B |
Stock-based compensation expense | 0 | 245M | 244M | 274M | 252M | 284M | 263M | 250M | 206M | 206M |
| Deferred income tax benefit | 0 | 245M | 244M | 274M | 252M | 284M | 263M | 250M | 206M | 206M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -397M | -777M | 185M | -134M | -462M | -35M | -529M | 168M | -493M | -20M |
Inventories | -840M | -927M | -357M | -593M | -547M | -701M | -145M | -326M | -466M | -8M |
Accounts payable | 402M | 452M | 451M | 86M | 169M | 270M | 577M | 447M | 241M | 459M |
Cash generated by operating activities | 10.25B | 10.52B | 10.52B | 7.41B | 7.74B | 5.54B | 7.37B | 8.18B | 8.92B | 7.69B |
Investing activities | ||||||||||
Purchases Of Investments | -134M | -488M | -311M | -137M | -38M | -137M | -161M | -108M | -142M | -571M |
Investments In Property Plant And Equipment | -3.25B | -2.20B | -2.04B | -2.08B | -1.81B | -1.97B | -1.95B | -2.08B | -2.77B | -1.45B |
Acquisitions Net | -3.82B | -858M | -5.55B | 5.03B | -488M | -12.85B | -1.15B | -426M | -220M | -1.72B |
Cash generated by investing activities | -6.2B | -2.07B | -7.29B | 3.61B | -1.05B | -12.87B | 639M | -2.63B | -3.25B | -3.46B |
Financing activities | ||||||||||
Common Stock Issued | 195M | 188M | 186M | 203M | 162M | 177M | 319M | 305M | 574M | 681M |
Payments for dividends | -4.45B | -4.16B | -4.00B | -3.93B | -3.83B | -3.77B | -3.71B | -3.75B | -3.69B | -3.67B |
Repurchases of common stock | -593M | -497M | -382M | -822M | -9M | -1.10B | -2.16B | -2.90B | -1.78B | -1.80B |
Repayments of term debt | -3.13B | -1.46B | -2.39B | -4.18B | -491M | -787M | -2.29B | -2.57B | 1.34B | -3.03B |
Cash used in financing activities | -8.05B | -5.82B | -7.05B | -6.48B | -4.19B | 3.93B | -7.90B | -3.99B | -3.60B | -5.18B |
Net Change In Cash | -4.02B | 2.63B | -3.81B | 4.48B | 2.50B | -3.39B | 42M | 1.45B | 1.80B | -916M |
Cash at end of period | 8.71B | 12.73B | 10.09B | 13.91B | 9.42B | 6.92B | 10.31B | 10.60B | 9.14B | 7.34B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |